Our articles keep health professionals up-to-date with the happenings throughout the industry.
Scroll

Clinical Articles

HPS Pharmacies prides itself on providing innovative and informative support to assist in the diverse range of issues health professionals face on a day-to-day basis, and to facilitate the distribution of this information for a variety of sectors within the healthcare industry.

HPS’ clinical articles are written by HPS Pharmacies’ experienced and knowledgeable staff and are peer-reviewed by specialist leaders in their field to ensure the accuracy of the information provided. The resourceful and diverse range of articles play an integral role in keeping all health professionals up-to-date with the happenings throughout the industry on a regular basis.

An Overview of Fungi

The fungal kingdom encompasses a range of diverse species, including moulds, yeasts, and mushrooms. It has been estimated that there are between 2.2 and 3.8 million species of fungi. All fungi are eukaryotic organisms…

Read more

Lower Urinary Tract Symptoms in Men

  Lower urinary tract symptoms (LUTS) are common in men and increase with age. These symptoms can be classified as either voiding symptoms or storage symptoms. Voiding symptoms are often related to prostate enlargement….

Read more

Weight Loss Medications

Overweight and obesity are the second leading risk factors for ill health and death in Australia, second only to tobacco use. Excess weight is linked to 30 diseases, including some cancers, cardiovascular disease, and…

Read more

Revised Hip Fracture Clinical Care Standard

The Australian Commission on Safety and Quality in Healthcare (ACSQHC) has just released the revised Hip Fracture Clinical Care Standard (2023). This publication provides guidance on pain management, time to surgery, mobilisation, and prevention…

Read more

Antibiotic Use in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is estimated to affect around 5% of people over 45 years of age, yet accounts for over half of the disease burden due to respiratory conditions. This progressive condition…

Read more

Erythropoietin Resistance

Erythropoiesis-stimulating agents (ESAs) are used to promote the production of erythrocytes. This medication group includes recombinant human erythropoietin (EPO) derivatives (e.g. epoetin alfa, epoetin beta, and epoetin lambda) and chemically modified forms of EPO…

Read more
Load More